Gangnam Severance Hospital

Seoul, Korea, Republic of
University hospital in Seoul
211 Eonju-ro, Gangnam-gu, Seoul

About Gangnam Severance Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gangnam Severance Hospital
57
Yonsei University
29
Hoffmann-La Roche
16
Seung-Jung Park
13
Seoul National University Hospital
10
Chong Kun Dang Pharmaceutical
9
National Cancer Institute (NCI)
9
Gilead Sciences
6
Severance Hospital
6
Janssen Research & Development, LLC
5
Ajou University School of Medicine
4
Total Rows: 100

Clinical Trials at Gangnam Severance Hospital


During the past decade, Gangnam Severance Hospital conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 37 clinical trials were completed, i.e. on average, 18.7% percent of trials that started reached the finish line to date. In the past 5 years, 94 clinical trials started and 24 clinical trials were completed. i.e. 25.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years171718182525171725253131222214142222224455331010333355Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
2007-09-01
2016-07-16
Completed
384
Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial
2006-02-01
2014-05-01
Unknown status
1,400
Pazopanib in Treating Patients With Metastatic Urothelial Cancer
2008-08-01
2013-12-01
Completed
19
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).
2009-03-01
2013-02-01
Completed
307
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
2009-02-09
2025-05-31
Active, not recruiting
877

Rows per page:

1–100 of 294

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gangnam Severance Hospital" #1 sponsor was "Gangnam Severance Hospital" with 57 trials, followed by "Yonsei University" with 29 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored, "Seung-Jung Park" with 13 trials sponsored and "Seoul National University Hospital" with 13 trials sponsored. Other sponsors include 164 different institutions and companies that sponsored additional 103 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gangnam Severance Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 13 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Severance Hospital" with 6 trials as a collaborator and "Asan Medical Center" with 5 trials as a collaborator. Other collaborators include 108 different institutions and companies that were collaborators in the rest 91 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGangnam SeveranceHospital: 57Gangnam SeveranceHospital: 57Yonsei University: 29Yonsei University: 29Hoffmann-La Roche: 16Hoffmann-La Roche: 16Seung-Jung Park: 13Seung-Jung Park: 13Seoul NationalUniversity Hospital: 10Seoul NationalUniversity Hospital: 10Chong Kun DangPharmaceutical: 9Chong Kun DangPharmaceutical: 9National Cancer Institute (NCI): 9National Cancer Institute (NCI): 9Gilead Sciences: 6Gilead Sciences: 6Severance Hospital: 6Severance Hospital: 6Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5

Created with Highcharts 11.1.0Top CollaboratorsCardioVascularResearch Foundation,Korea: 13CardioVascularResearch Foundation,Korea: 13NRG Oncology: 9NRG Oncology: 9National Cancer Institute (NCI): 9National Cancer Institute (NCI): 9Severance Hospital: 6Severance Hospital: 6Asan Medical Center: 5Asan Medical Center: 5Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4Samsung Medical Center: 4Samsung Medical Center: 4Seoul NationalUniversity Hospital: 4Seoul NationalUniversity Hospital: 4Gangnam Severance Hospital: 3Gangnam Severance Hospital: 3Kyungpook NationalUniversity Hospital: 3Kyungpook NationalUniversity Hospital: 3

Clinical Trials Conditions at Gangnam Severance Hospital


According to Clinical.Site data, the most researched conditions in "Gangnam Severance Hospital" are "Breast Cancer" (18 trials), "Coronary Artery Disease" (16 trials), "Gastric Cancer" (10 trials), "Hypertension" (8 trials) and "Cervical Cancer" (7 trials). Many other conditions were trialed in "Gangnam Severance Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Gangnam Severance Hospital


Most popular intervention types in "Gangnam Severance Hospital" are "Drug" (187 trials), "Procedure" (41 trials), "Device" (38 trials), "Other" (28 trials) and "Biological" (22 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "Paclitaxel" (15 trials), "Carboplatin" (11 trials), "Quality-of-Life Assessment" (8 trials) and "Laboratory Biomarker Analysis" (7 trials). Other intervention names were less common.

Clinical Trials Genders at Gangnam Severance Hospital


The vast majority of trials in "Gangnam Severance Hospital" are 246 trials for "All" genders, 42 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Gangnam Severance Hospital


Currently, there are NaN active trials in "Gangnam Severance Hospital". 2 are not yet recruiting, 49 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 131 completed trials in Gangnam Severance Hospital, undefined suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Gangnam Severance Hospital, 16 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 65 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 87Phase 3: 87Not Applicable: 65Not Applicable: 65Phase 2: 55Phase 2: 55Phase 4: 42Phase 4: 42Phase 1: 16Phase 1: 16

Created with Highcharts 11.1.0Trials StatusCompleted: 131Completed: 131Unknown status: 58Unknown status: 58Recruiting: 49Recruiting: 49Active, not recruiting: 37Active, not recruiting: 37Terminated: 15Terminated: 15Not yet recruiting: 2Not yet recruiting: 2Available: 1Available: 1Withdrawn: 1Withdrawn: 1